Onco-Innovations Limited (ONCO) | Finanzwire

Basculer en Français

8630	Companies
143980	Keywords
79657	Articles
76974	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 04/25/2025 at 00:05, 2 days 16 hours ago

Onco-Innovations' Inka Health Partners with AstraZeneca Canada

Real-world Evidence Onco-Innovations Inka Health AstraZeneca Canada Drug Submission
PRESS RELEASE

published on 04/25/2025 at 00:00, 2 days 16 hours ago

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access

Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF

published on 04/18/2025 at 00:05, 9 days 16 hours ago

Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis

Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
PRESS RELEASE

published on 04/18/2025 at 00:00, 9 days 16 hours ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 10 days 14 hours ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
PRESS RELEASE

published on 04/17/2025 at 01:30, 10 days 14 hours ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited
BRIEF

published on 04/11/2025 at 00:05, 16 days 16 hours ago

Onco-Innovations' Inka Health Advances Real-World Oncology Research

Clinical Trials Oncology Research Real-world Data Quantitative Bias Analysis Regulatory Assessments
PRESS RELEASE

published on 04/11/2025 at 00:00, 16 days 16 hours ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Onco-Innovations Limited announces groundbreaking study on adjusting bias in real-world oncology research, published in JAMA Network Open, offering a method to enhance clinical comparisons

Bias Analysis Onco-Innovations Limited Real-world Oncology Research JAMA Network Open Clinical Comparisons
BRIEF

published on 04/04/2025 at 00:05, 23 days 16 hours ago

Inka Health's Analytical Achievements for AstraZeneca Canada Highlighted at ISPOR 2025

Real-world Evidence Pharmaceutical Analytics ISPOR 2025 Healthcare Decision-Making AstraZeneca Collaboration
PRESS RELEASE

published on 04/04/2025 at 00:00, 23 days 16 hours ago

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use

Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation

1 2 ... 5

Accesswire

Published on 04/26/2025 at 02:00, 1 day 14 hours ago

Battery X Metals Announces Strategic Agreement to Advance Artificial Intelligence-Driven Exploration of Critical Battery Metals in Nevada, USA
Published on 04/25/2025 at 23:30, 1 day 16 hours ago

AIML Innovations Announces Departure of Tim Daniels from Board of Directors
Published on 04/25/2025 at 23:01, 1 day 17 hours ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
Published on 04/25/2025 at 23:00, 1 day 17 hours ago

AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Published on 04/25/2025 at 22:15, 1 day 18 hours ago

Grande Portage Resources Announces Extension of Expiry Date for Warrants

View all ACCESSWIRE

EQS Group

Published on 04/25/2025 at 22:47, 1 day 17 hours ago

DEAG achieves new revenue level in “transformation year” 2024 – Strategic investments and strong start to the year create basis for future sustainable growth
Published on 04/25/2025 at 20:30, 1 day 19 hours ago

EQS-Adhoc: Nagarro SE: Confirms 2024 guidance and dividend, postpones publication for full-year results
Published on 04/25/2025 at 18:44, 1 day 21 hours ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 04/25/2025 at 18:31, 1 day 21 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/25/2025 at 18:30, 1 day 21 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 04/25/2025 at 18:16, 1 day 22 hours ago

PR_Carrefour Brazil_25042025
Published on 04/25/2025 at 18:05, 1 day 22 hours ago

Louis Hachette Group - 2025 First-quarter revenue
Published on 04/25/2025 at 18:00, 1 day 22 hours ago

Availability of the 2024 universal registration document
Published on 04/25/2025 at 18:00, 1 day 22 hours ago

Postponement of the publication of the annual financial statements
Published on 04/25/2025 at 17:45, 1 day 22 hours ago

LANSON-BCC: GENERAL SHAREHOLDERS’ MEETING ON APRIL 25, 2025 - DIVIDEND: €0.90 PER SHARE

View all LES ECHOS COMFI WIRE